Bethany George

The assembly line for AI initiatives. Build a scalable process to refine and approve AI initiatives in one collaborative platform.

QicScan AI provides the latest machine vision-based data capture and barcode scanning solutions to the healthcare and food industries. Were on a mission to improve operational productivity and efficiency while addressing the issues around DSCSA compliance and traceability.

HyperPath Solutions, Inc., is a early-stage startup.

Asynt Solutions employs cutting-edge materials and state-of-the-art manufacturing technology to engineer innovative products tailored for transportation infrastructure and heavy construction, aiming to enhance safety, worksite efficiency, and minimize environmental impacts. Our inaugural product line, the APE Barrier System, are composite temporary traffic barriers that have demonstrated the ability to absorb 50% more energy compared to traditional concrete portable barriers, all while weighing only 1/10th as much. This unique feature allows contractors to transport a significantly greater number of barriers per truck load, accelerating installation processes and ensuring job site safety. Additionally, it contributes to heightened safety for the public during highway travel. Learn more about the APE Barrier System on our website.

Eikonoklastes Therapeutics is an early stage biopharmaceutical company focused on rapidly advancing innovative medicines for numerous areas of significant unmet clinical need, starting with neurodegenerative diseases. We are iconoclasts who are passionate about finding new and better ways to treat disease. Our first-in-class gene therapy moves beyond single defective gene replacement. It is a transformational, disease-modifying gene supplement therapy with a unique mechanism of action that provides extra copies of a critical gene to cause overexpression of a critical neurotrophic factor that is essential for neuromuscular signaling and function. Our initial focus is on Amyotrophic Lateral Sclerosis (ALS, Lou Gehrig’s Disease), a rare, yet debilitating nerve disease that causes progressive muscle degeneration and eventual death. An estimated 5,000 new patients in the U.S. are diagnosed each year with ALS, and there are few treatment options beyond supportive care. Our dynamic discovery and development approach allows us to focus on accelerated approvals and outsized returns for ALS and potentially other neurodegenerative diseases such as Parkinson’s, Huntington’s, Alzheimer’s, traumatic brain injury, and more.

INVIRSA, INC. is a company based out of 2807 DELMAR DR, Bexley, Ohio, United States.

Invirsa is developing a small molecule (INV-102) that promotes both DNA repair and the innate immune response to infection and injury. These actions lead to enhanced wound healing associated with reductions in inflammation and viral replication. INV-102 has demonstrated unprecedented efficacy in animal models of ocular sulfur mustard gas injury. Sulfur mustard is a dangerous chemical weapon, and INV-102 is the first drug to show promise in preventing its long-term effects. There is no current FDA approved therapy for this injury. In September of 2020, Invirsa received a $29.6M BARDA award ($14.4M plus $15.2M in milestones) to support the clinical development of INV-102 for the treatment of ocular sulfur mustard gas injury and other ocular injuries associated with DNA damage. The award covers development through Phase 3 clinical trials. Invirsa’s initial commercial focus for INV-102 will be infectious keratoconjunctivitis as there is no treatment for the viral form of this disease which comprises 80% of all cases. INV-102 has demonstrated clear efficacy in animal models of infectious conjunctivitis.

At The Toasted Oat, we know the importance of clean living and simple ingredients. Our soft and chewy, completely addictive granola is hand-crafted using our family recipe along with all natural, unprocessed, nonGMO ingredients you can trust. We are committed to creating safe Gluten-Free products, and strictly adhere to GFCO certification standards. The Toasted Oat is the ONLY GRANOLA families are fighting over!

SafeWire exists to insure and ensure every real estate transaction is free from wire fraud. Real estate wire fraud is a problem arising from global financial inequality. Often, the criminals involved are from poor countries throughout the world who feel that they are Robin Hood, stealing from the rich to give to the poor. If we’re going to define success with our mission and build a FraudFree™ world, SafeWire will need to positively impact global financial inequality in parts of the world where online fraud is born. Real estate wire fraud isn’t sexy. It is however, a massive problem for the traditional real estate industry. Business Email Compromise (BEC) Fraud has cost over $9B* since 2016. 16% of those losses are specific to Real Estate Wire Fraud.

MavenVue provides strategic insights for health and life science professionals by revealing connections and patterns that inform Innovation, Competitive Intelligence, Licensing, and M&A Activities. MavenView gives high-level overviews of technologies, applications and the players in the space, as well as deep-dives into biologic therapies and rare diseases.

Rapchat is on a mission to democratize music creation with mobile tools that allow anyone to be a music artist. Rapchat takes the friction out of making music and has helped over 10 million artists unleash their creativity.

Nexosis makes it simple to start building machine learning applications. Our dashboard and API give you easy access to automated, scalable model building and deployment. The best part? We empower you to use machine learning regardless of your understanding of data science.

The assembly line for AI initiatives. Build a scalable process to refine and approve AI initiatives in one collaborative platform.

QicScan AI provides the latest machine vision-based data capture and barcode scanning solutions to the healthcare and food industries. Were on a mission to improve operational productivity and efficiency while addressing the issues around DSCSA compliance and traceability.

HyperPath Solutions, Inc., is a early-stage startup.

Asynt Solutions employs cutting-edge materials and state-of-the-art manufacturing technology to engineer innovative products tailored for transportation infrastructure and heavy construction, aiming to enhance safety, worksite efficiency, and minimize environmental impacts. Our inaugural product line, the APE Barrier System, are composite temporary traffic barriers that have demonstrated the ability to absorb 50% more energy compared to traditional concrete portable barriers, all while weighing only 1/10th as much. This unique feature allows contractors to transport a significantly greater number of barriers per truck load, accelerating installation processes and ensuring job site safety. Additionally, it contributes to heightened safety for the public during highway travel. Learn more about the APE Barrier System on our website.

JumpStart Ventures is a top-performing Venture Investor with a 20-year legacy of Impact Investing at JumpStart Inc. We empower innovation through multiple funds, managed collectively to provide a continuum of capital from Pre-seed, Seed to Series A and beyond. With more than $140M under management, we have invested in over 160 high-potential, early-stage startups throughout Ohio and the Midwest by providing critical resources, industry connections, and high-impact capital. We back bold start-ups who strive to generate exponential returns and transform the tech ecosystem, focusing in areas such as software, healthcare IT, biotechnology and more.